EP Patent

EP2262536A2 — Stabilizing lipid compositions for oral pharmaceutical agents

Assigned to Taro Pharmaceuticals North America Inc · Expires 2010-12-22 · 15y expired

What this patent protects

The present invention relates to a pharmaceutical composition for oral administration comprising an exceptionally labile active agent, a stabilizing vehicle comprising liquid triglycerides and a desiccant, wherein the composition is storage stable for an extended period without s…

USPTO Abstract

The present invention relates to a pharmaceutical composition for oral administration comprising an exceptionally labile active agent, a stabilizing vehicle comprising liquid triglycerides and a desiccant, wherein the composition is storage stable for an extended period without substantial degradation of the active agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP2262536A2
Jurisdiction
EP
Classification
Expires
2010-12-22
Drug substance claim
No
Drug product claim
No
Assignee
Taro Pharmaceuticals North America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.